SNDL Stock Gained 19.5% in November: Is it a Buy Today?

SNDL is a beaten-down Canadian cannabis producer and has trailed the market since its IPO. Is SNDL stock a buy or sell right now?

| More on:
A cannabis plant grows.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of SNDL (NASDAQ:SNDL) rose by almost 20% last month, valuing the Canadian cannabis company at a market cap of US$666.7 million. However, similar to other pot stocks, SNDL has also trailed the broader markets by a significant margin and is down 98% from all-time highs.

Created with Highcharts 11.4.3SNDL PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

A key driver of SNDL’s stock price in November was the announcement of third-quarter (Q3) results. In the September quarter, SNDL reported revenue of $230.5 million, which was much higher than estimates of $172 million. But the company also reported a net loss of $98.8 million compared to its year-ago profit of $16.7 million.

SNDL was majorly impacted by non-cash impairments, which amounted to $86.5 million. However, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) stood at $18.3 million.

While the company’s recent quarterly results were cheered by investors, let’s see if SNDL stock is a top bet for long-term shareholders.

Is SNDL a good stock to buy?

SNDL recently announced the acquisition of Zenabis, a cannabis producer which filed for creditor protection. While this acquisition might not be viewed in a positive light by shareholders, it will allow SNDL to gain traction in the European Union, as Zenabis owns a GMP-certified (good manufacturing process) marijuana facility in Europe.

SNDL also disclosed plans to acquire cannabis extraction company Valens in an all-stock deal valued at $138 million. These acquisitions will make SNDL a top-10 player in the Canadian marijuana market.

SNDL ended Q3 with $325.6 million in cash, providing it with enough liquidity in the near term. It benefitted from the meme stock craze in 2021, allowing the company to raise $1 billion in cash and reduce balance sheet debt.

SNDL used the cash to acquire Alcanna, an alcohol retailer with a strong presence in Alberta. It also owns a majority stake in Nova Cannabis, the parent company of the Value Buds retail brand. Both these deals provided SNDL with a platform to expand its retail footprint and generate a positive cash flow in the future.

SNDL also formed a joint venture with SAF Group called SunStream. The joint venture provides debt to cannabis producers south of the border, enabling SNDL to enter the largest cannabis market in the world.

What’s next for SNDL stock and investors?

It’s quite possible that SNDL will continue to take advantage of a challenging macro environment and expand inorganically by purchasing potential targets at a discount. These acquisitions are expected to increase the company’s revenue from $42 million in 2021 to $719 million in 2023.

SNDL’s aggressive acquisition plans may also result in higher operating expenses. But the company reported a positive operating cash flow of $8.6 million in Q3 compared to a negative operating cash flow of $17.9 million in Q2.

While the third quarter surprised Bay Street, SNDL has to maintain its focus on improving cash flow and profit margins. Most Canadian cannabis players are grappling with oversupply and high inventory levels. This, in turn, results in significant writedowns and mounting losses.

SNDL stock is a high-risk bet, given that Canadian cannabis producers are impacted by a range of structural issues. But analysts remain bullish on SNDL stock and expect shares to rise by 45% in the next year.

Should you invest $1,000 in Sndl right now?

Before you buy stock in Sndl, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Sndl wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Valens. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »